Research on epithalon, particularly in older animal models, has shown improvements in immune cell function and antibody production
Once mast cell activation is identified as a key driver of neuroautoimmunity, the clinical objective shifts toward calming the immune system, restoring barrier integrity, and reducing inflammatory burden
Individuals with chronic health conditions such as autoimmune disorders or chronic fatigue, who may experience improved immune function and reduced inflammation
Anti-apoptotic protein upregulation Bcl-2 family regulation: Balance between pro-apoptotic (Bax, Bad, Bid) and anti-apoptotic (Bcl-2, Bcl-xL, Mcl-1) Bcl-2 family members determines cell survival versus death
Excess NEFAs, which stimulate the secretion of insulin, disrupt the function of cells by increasing basal insulin levels but inhibit GSIS